30 results
Page 2 of 2
10-KT
2z215r i5cotk0kyme90
26 Mar 18
Annual report (with FYE transition)
12:00am
8-K
EX-1.1
e05ve
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-99.1
w2ep40xhkx 7qfu76
7 Jan 15
ContraVir Pharmaceuticals Granted FDA Meeting to Discuss Proposal for Phase 3 Trial of FV-100
12:00am
10-12G/A
EX-99.1
j7crcyhj9y0qnb
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
t7ecsk4vpo
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
tc3yxxti06ois2wrsstu
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
x0lat53trmugaechy7
22 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
30c4 t17x3
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-99.1
qmf4jftaduhmun2hhb
8 Aug 13
Registration of securities
12:00am